Robuta

https://www.nature.com/articles/s41598-026-42166-y?error=cookies_not_supported&code=2bb88c56-a710-477d-8a21-cf9c21b3ab1d Anti-obesity medication use sparks effort-based sanctions and social penalties | Scientific Reports Apr 22, 2026 - Obesity is one of the most widespread public health risks, with more than 1 billion affected individuals worldwide. While treatment with ‘anti-obesity’... anti obesity medicationscientific reports https://news.ki.se/more-children-are-receiving-obesity-medication More children are receiving obesity medication | Karolinska Institutet Mar 3, 2026 - For several years, the rates for childhood obesity have been fairly stable. However, the use of new drugs is increasing. more childrenobesity medicationkarolinska institutetreceiving https://www.iqvia.com/library/white-papers/nutrition-as-the-keystone-for-obesity-management-medication Nutrition as the Keystone for Obesity Management Medication | IQVIA Discover IQVIA Consumer Health's white paper Nutrition as the Keystone for Obesity Management Medication, exploring how GLP-1 therapies are reshaping obesity... obesity managementnutritionkeystonemedicationiqvia https://www.youembody.com/health-wellness/weight-loss/workshops/glp1s-weight-loss-medications-treatments GLP-1s, Weight Loss Medication & Obesity Treatments Today GLP-1s are a popular and effective weight loss medication, but other obesity treatments exist beyond semaglutide and trizepatide. weight loss medicationobesity treatmentsglp1stoday